Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Long-Term Prediction
This study has been completed.
Sponsor:
Deutsches Herzzentrum Muenchen
Information provided by:
Deutsches Herzzentrum Muenchen
ClinicalTrials.gov Identifier:
NCT00196261
First received: September 13, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to investigate the performance of established and new risk preditors in predicting long term-mortality (up to ten years) of post-infarction patients.
| Condition |
|---|
|
Infarction, Myocardial |
| Study Type: | Observational |
| Study Design: | Observational Model: Defined Population Primary Purpose: Screening Time Perspective: Longitudinal Time Perspective: Prospective |
| Official Title: | Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Long-Term Prediction |
Further study details as provided by Deutsches Herzzentrum Muenchen:
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
acute myocardial infarction
Exclusion Criteria:
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00196261
Locations
| Germany | |
| Deutsches Herzzentrum Muenchen | |
| Munich, Germany, 80636 | |
| 1. Medizinische Klinik, Klinikum rechts der Isar | |
| Munich, Germany, 81675 | |
Sponsors and Collaborators
Deutsches Herzzentrum Muenchen
Investigators
| Study Chair: | Georg Schmidt, MD | Deutsches Herzzentrum Muenchen |
| Study Director: | Petra Barthel, MD | Deutsches Herzzentrum Muenchen |
| Principal Investigator: | Axel Bauer, MD | Deutsches Herzzentrum Muenchen |
More Information
Additional Information:
Publications:
| ClinicalTrials.gov Identifier: | NCT00196261 History of Changes |
| Other Study ID Numbers: | GE IDE No. R00195 |
| Study First Received: | September 13, 2005 |
| Last Updated: | September 13, 2005 |
| Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
Keywords provided by Deutsches Herzzentrum Muenchen:
|
Assessment, Risk Autonomic nervous system |
Additional relevant MeSH terms:
|
Infarction Myocardial Infarction Ischemia Pathologic Processes Necrosis |
Myocardial Ischemia Heart Diseases Cardiovascular Diseases Vascular Diseases |
ClinicalTrials.gov processed this record on May 21, 2013